Back to Search Start Over

Poster Presentations

Authors :
N. Sutamam
Florent Ginhoux
Barnaby Edward Young
Akshamal M. Gamage
Karen Donceras Nadua
Pavanish Kumar
Chee Fu Yung
Natalie Woon Hui Tan
Amanda Jin Mei Lim
D. Guo
Cheng Tung Chong
K. S. Yeo
Su Li Poh
Jiahui Li
Jing Yao Leong
Randy Foo
Katherine Nay Yaung
Xiao Qian Ng
Joo Guan Yeo
David C. Lye
Camillus Chua
Sharifah Nur Hazirah
Martin Qui
Jerry Kok Yen Chan
Martin Wasser
Lin-Fa Wang
Thaschawee Arkachaisri
Kai Qian Kam
Koh Cheng Thoon
Danielle E. Anderson
Salvatore Albani
L. Ramakrishna
Shi Huan Tay
Source :
International Journal of Rheumatic Diseases. 24:121-333
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

Background/Purpose: The global coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in significant mortality, social disorder and economic hardships. We set out to understand why certain individuals could resolve the disease successfully without serious complications by immune profiling of PBMCs from convalescent COVID-19 patients (n = 14) with mild disease trajectory. Methods: We designed 7 peptides targeting the receptor binding region (RBD) of the spike protein of SARS-CoV-2, that encompass broad HLA class I / II alleles, with the aid of the Immune Epitope Database and Analysis Resource (IEDB) website. The RBD site was chosen as it was shown to be protective when neutralising antibodies against this region could negate binding of viral spike protein to host cell ACE-2 receptor. Convalescent COVID-19 patients enrolled in this study were screened and selected for positive antibody titre against the RBD region. PBMCs from convalescent COVID-19 patients were stimulated with/without the peptides for 72hrs and immune profiled (n = 70 markers across two panels) with the high dimensional single cell mass cytometry platform (CyToF). Results: Convalescent COVID-19 patients elicited a robust recall memory T follicular helper response (CD3 + CD4 + CD45RO + CXCR5 + Tigit + ;∗∗∗∗ p < 0.0001) demonstrating peptide efficacy. Unsupervised clustering (FlowSOM) of the CD4 T cell immune landscape reaffirmed increase in memory T follicular subsets and additionally CD4 + CD45RO + CXCR5 -subsets. Further gating of antigen specific memory cells (CD45RO + CD69 + ) revealed an increase in Tbet + CXCR3 + T effectors in both CD4 and CD8 compartments. Strikingly we detected a parallel increase in CD4 + Treg (CD25 + FoxP3 + ) CXCR3 + Tbet + CD45RO + CD152 + Tigit + expression. Conclusions: COVID-19 patients that successfully resolve the viral infection not only mount a robust T effector and follicular response but also in tandem a similar T regulatory profile.

Details

ISSN :
1756185X and 17561841
Volume :
24
Database :
OpenAIRE
Journal :
International Journal of Rheumatic Diseases
Accession number :
edsair.doi...........5b383829438daec2cdd3508e1c883e16
Full Text :
https://doi.org/10.1111/1756-185x.14200